Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
16.05
-0.15 (-0.93%)
At close: Apr 28, 2026, 4:00 PM EDT
16.08
+0.03 (0.19%)
After-hours: Apr 28, 2026, 7:47 PM EDT
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Healthpeak Properties stock have an average target of 19.04, with a low estimate of 17 and a high estimate of 25. The average target predicts an increase of 18.63% from the current stock price of 16.05.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 6 | 7 | 8 | 8 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +12.15% | Apr 28, 2026 |
| Baird | Baird | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +18.38% | Apr 6, 2026 |
| Citigroup | Citigroup | Hold Maintains $18 → $18 | Hold | Maintains | $18 → $18 | +9.03% | Apr 1, 2026 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 5, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +18.38% | Feb 4, 2026 |
Financial Forecast
Revenue This Year
2.88B
from 2.82B
Increased by 1.93%
Revenue Next Year
3.04B
from 2.88B
Increased by 5.49%
EPS This Year
0.22
from 0.10
Increased by 117.15%
EPS Next Year
0.25
from 0.22
Increased by 13.18%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.2B | 3.6B | ||||||
| Avg | 2.9B | 3.0B | ||||||
| Low | 2.7B | 2.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 14.0% | 25.0% | ||||||
| Avg | 1.9% | 5.5% | ||||||
| Low | -4.8% | -3.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 0.28 | 0.35 | ||||||
| Avg | 0.22 | 0.25 | ||||||
| Low | 0.15 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 183.5% | 59.6% | ||||||
| Avg | 117.2% | 13.2% | ||||||
| Low | 47.0% | -32.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.